Furiex Pharmaceuticals, Inc. - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - March 18, 2011

Attached files

file filename
10-K - FORM 10-K - Furiex Pharmaceuticals, Inc.d10k.htm
EX-21.1 - SUBSIDIARIES - Furiex Pharmaceuticals, Inc.dex211.htm
EX-31.1 - CERTIFICATION OF CMO PURSUANT OT SECTION 302 OF THE SARBANES-OXLEY ACT - Furiex Pharmaceuticals, Inc.dex311.htm
EX-32.1 - CERTIFICATION OF CMO PURSUANT OT SECTION 906 OF THE SARBANES-OXLEY ACT - Furiex Pharmaceuticals, Inc.dex321.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT OT SECTION 302 OF THE SARBANES-OXLEY ACT - Furiex Pharmaceuticals, Inc.dex312.htm
EX-32.2 - CERTIFICATION OF CFO PURSUANT OT SECTION 906 OF THE SARBANES-OXLEY ACT - Furiex Pharmaceuticals, Inc.dex322.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in Registration Statement No. 333-167552 on Form S-8 of our report dated March 18, 2011 relating to the combined and consolidated financial statements of Furiex Pharmaceuticals, Inc. and Subsidiaries, appearing in this Annual Report on Form 10-K of Furiex Pharmaceuticals, Inc. for the year ended December 31, 2010.

/s/ DELOITTE & TOUCHE LLP

Raleigh, North Carolina

March 18, 2011

Furiex Pharmaceuticals, Inc. Reports

Also read